Furthermore, immunohistochemistry (IHC) staining of 150 ccRCC tissue microarrays (TMAs) confirmed higher PLOD2 protein levels in advanced-stage tumors (Fig. 6F-H). This evidence concerns the gene PLOD2 and nonpapillary renal cell carcinoma.